Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide

Journal of Clinical Investigation

Volumn 118, Issue 12, 2008, Pages 3980-3989

  Straub, Adam C ^a   Clark, Katherine A ^b   Ross, Mark A ^b   Chandra, Ashwin G ^a   Li, Song ^a   Gao, Xiang ^a   Pagano, Patrick J ^b   Stolz, Donna B ^a,b   Barchowsky, Aaron ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CD31 ANTIGEN; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; KNOCKOUT MOUSE; LIVER SINUSOID; MOUSE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTROCHEMICAL MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIGENS, CD31; ARSENIC; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; NEUROPEPTIDES; RAC GTP-BINDING PROTEINS; SUPEROXIDES; WATER POLLUTANTS, CHEMICAL;

EID: 57449104408     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35092     Document Type: Article

References (48)

1. Zierold, K.M., Knobeloch, L., and Anderson, H. 2004. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am. J. Public Health. 94:1936-1937.
2. Navas-Acien, A., et al. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162:1037-1049.
3. Meliker, J.R., Wahl, R.L., Cameron, L.L., and Nriagu, J.O. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ. Health. 6:4.
4. Soucy, N.V., et al. 2005. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc.Toxicol. 5:29-42.
5. Kamat, C.D., et al. 2005. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol. Sci. 86:248-257.
6. Yuan, Y., et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 166:1381-1391.
7. Chen, Y., et al. 2007. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am. J. Epidemiol. 165:541-552.
8. Hsueh, Y.M., et al. 2005. Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J. Toxicol. Environ. Health A. 68:1471-1484.
9. Mazumder, D.N. 2005. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 206:169-175.
10. Falkowska-Hansen, B., Falkowski, M., Metharom, P., Krunic, D., and Goerdt, S. 2007. Clathrin-coated vesicles form a unique net-like structure in liver sinusoidal endothelial cells by assembling along undisrupted microtubules. Exp. Cell Res. 313:1745-1757.
11. Elvevold, K., Smedsrod, B., and Martinez, I. 2008. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G391-G400.
12. Warren, A., et al. 2006. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology. 44:1182-1190.
13. Hilmer, S.N., et al. 2005. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology. 42:1349-1354.
14. DeLeve, L.D. 2007. Hepatic microvasculature in liver injury. Semin. Liver Dis. 27:390-400.
15. DeLeve, L.D., Wang, X., Hu, L., McCuskey, M.K., and McCuskey, R.S. 2004. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am. J. Physiol. Gastrointest. Liver Physiol. 287:G757-G763.
16. DeLeve, L.D., Wang, X., and Guo, Y. 2008. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology. 48:920-930.
17. Hasegawa, T., et al. 2002. Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. Liver. 22:321-329.
18. Cogger, V.C., et al. 2004. The effects of oxidative stress on the liver sieve. J. Hepatol. 41:370-376.
19. Cogger, V.C., et al. 2006. Hyperlipidemia and surfactants: The liver sieve is a link. Atherosclerosis. 189:273-281.
20. McLean, A.J., et al. 2003. Age-related pseudocapillarization of the human liver. J. Pathol. 200:112-117.
21. Brock, R.W., and Dorman, R.B. 2007. Obesity, insulin resistance and hepatic perfusion. Microcirculation. 14:339-347.
22. Straub, A.C., et al. 2007. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology. 45:205-212.
23. Straub, A.C., et al. 2007. Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. Toxicol. Appl. Pharmacol. 222:327-336.
24. Ushio-Fukai, M., and Alexander, R.W. 2004. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 264:85-97.
25. Lyle, A.N., and Griendling, K.K. 2006. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda). 21:269-280.
26. Smith, K.R., Klei, L.R., and Barchowsky, A. 2001. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L442-L449.
27. Lynn, S., Gurr, J.R., Lai, H.T., and Jan, K.Y. 2000. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:514-519.
28. Rey, F.E., Cifuentes, M.E., Kiarash, A., Quinn, M.T., and Pagano, P.J. 2001. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ. Res. 89:408-414.
29. Gao, Y., Dickerson, J.B., Guo, F., Zheng, J., and Zheng, Y. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. U. S. A. 101:7618-7623.
30. Xu, B., et al. 2003. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am. J. Pathol. 163:1275-1289.
31. Tsuneyama, K., et al. 2003. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology. 43:55-61.
32. Flora, S.J., Pant, S.C., Malhotra, P.R., and Kannan, G.M. 1997. Biochemical and histopathological changes in arsenic-intoxicated rats coexposed to ethanol. Alcohol. 14:563-568.
33. Dorman, R.B., et al. 2006. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G1025-G1032.
34. Quinn, M.T., Ammons, M.C., and DeLeo, F.R. 2006. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin. Sci. (Lond.). 111:1-20.
35. Kobayashi, S., Nojima, Y., Shibuya, M., and Maru, Y. 2004. Nox1 regulates apoptosis and potentially stimulates branching morphogenesis in sinusoidal endothelial cells. Exp.Cell Res. 300:455-462.
36. Reinehr, R., Becker, S., Eberle, A., Grether-Beck, S., and Haussinger, D. 2005. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280:27179- 27194.
37. Teufelhofer, O., et al. 2005. Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice. Carcinogenesis. 26:319-329.
38. Maharaj, A.S., Saint-Geniez, M., Maldonado, A.E., and D'Amore, P.A. 2006. Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 168:639-648.
39. Langer, D.A., and Shah, V.H. 2006. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis. J. Hepatol. 44:209-216.
40. Soucy, N.V., et al. 2003. Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol. Sci. 76:271-279.
41. Klei, L.R., and Barchowsky, A. 2008. Positive signaling interactions between arsenic and ethanol for angiogenic gene induction in human microvascular endothelial cells. Toxicol. Sci. 102:319-327.
42. Barchowsky, A., Klei, L.R., Dudek, E.J., Swartz, H.M., and James, P.E. 1999. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27:1405-1412.
43. Pi, J., et al. 2003. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic. Biol. Med. 35:102-113.
44. Bunderson, M., et al. 2004. Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol. 201:32-39.
45. Seglen, P.O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
46. Ross, M.A., Sander, C.M., Kleeb, T.B., Watkins, S.C., and Stolz, D.B. 2001. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology. 34:1135-1148.
47. Wack, K.E., et al. 2001. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology. 33:363-378.
48. Stolz, D.B., et al. 1999. Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. Am. J. Pathol. 155:1487-1498.